Duke-Cohan, J. S. et al. Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation. Nature 613, 565–574 (2023).
Silva-Santos, B. & Mensurado, S. γδ T cells preserve sensitivity to immunotherapy in MHC-I-deficient tumors. Nat. Immunol. 24, 387–388 (2023).
de Vries, N. L. et al. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature 613, 743–750 (2023).
Rancan, C. et al. Exhausted intratumoral Vδ2− γδ T cells in human kidney most cancers retain effector operate. Nat. Immunol. 24, 612–624 (2023).
Zhu, X. et al. Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses. Nat. Immunol. 24, 625–636 (2023).
Wu, Y. et al. An innate-like Vδ1 + γδ T cell compartment within the human breast is related to remission in triple-negative breast most cancers. Sci. Transl. Med. 11, eaax9364 (2019).
Mensurado, S., Blanco-Domínguez, R. & Silva-Santos, B. The rising roles of γδ T cells in most cancers immunotherapy. Nat. Rev. Clin. Oncol. 20, 178–191 (2023).
De Gassart, A. et al. Growth of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response. Sci. Transl. Med. 13, eabj0835 (2021).
Nishimoto, Ok. P. et al. Allogeneic CD20‐focused γδ T cells exhibit innate and adaptive antitumor actions in preclinical B‐cell lymphoma fashions. Clin. Transl. Immunol. 11, e1373 (2022).
Xu, Y. et al. Allogeneic Vγ9Vδ2 T-cell immunotherapy displays promising scientific security and prolongs the survival of sufferers with late-stage lung or liver most cancers. Cell. Mol. Immunol. 18, 427–439 (2021).
Dwivedi, S. F. V. P. Allicin as an adjunct immunotherapy towards tuberculosis. J. Cell. Immunol. 2, 78–182 (2020).
Li, Z. et al. Allicin reveals antifungal efficacy towards Cryptococcus neoformans by blocking the fungal cell membrane. Entrance. Microbiol. 13, 1012516 (2022).
Catanzaro, E., Canistro, D., Pellicioni, V., Vivarelli, F. & Fimognari, C. Anticancer potential of allicin: a overview. Pharmacol. Res. 177, 106118 (2022).
Nantz, M. P. et al. Supplementation with aged garlic extract improves each NK and γδ-T cell operate and reduces the severity of chilly and flu signs: a randomized, double-blind, placebo-controlled diet intervention. Clin. Nutr. 31, 337–344 (2012).
Goodridge, H. S. et al. Activation of the innate immune receptor dectin-1 upon formation of a ‘phagocytic synapse’. Nature 472, 471–475 (2011).
Iliev, I. D. et al. Interactions between commensal fungi and the C-type lectin receptor dectin-1 affect colitis. Science 336, 1314–1317 (2012).
Taylor, P. R. et al. Dectin-1 is required for β-glucan recognition and management of fungal an infection. Nat. Immunol. 8, 31–38 (2007).
Petermann, F. et al. γδ T cells improve autoimmunity by restraining regulatory T cell responses through an interleukin-23-dependent mechanism. Immunity 33, 351–363 (2010).
Worth, S. J. & Hope, J. C. Enhanced secretion of interferon-γ by bovine γδ T cells induced by coculture with Mycobacterium bovis-infected dendritic cells: proof for reciprocal activating alerts. Immunology 126, 201–208 (2009).
Sedlak, C., Patzl, M., Saalmuller, A. & Gerner, W. IL-12 and IL-18 induce interferon-γ manufacturing and de novo CD2 expression in porcine γδ T cells. Dev. Comp. Immunol. 47, 115–122 (2014).
Teo, H. Y. et al. IL-12/18/21 pre-activation enhances the anti-tumor efficacy of expanded γδT cells and overcomes resistance to anti-PD-L1 therapy. Most cancers Immunol. Res. 11, 978–999 (2022).
Beziaud, L. et al. IFNγ-induced stem-like state of most cancers cells as a driver of metastatic development following immunotherapy. Cell Stem Cell 30, 818–831.e816 (2023).
Kohlgruber, A. C. et al. γδ T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. Nat. Immunol. 19, 464–474 (2018).
Yong, L. et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic irritation through macrophages and keratinocytes in mice. Nat. Commun. 13, 4255 (2022).
Nielsen, M. M., Witherden, D. A. & Havran, W. L. γδ T cells in homeostasis and host defence of epithelial barrier tissues. Nat. Rev. Immunol. 17, 733–745 (2017).
Bagheri, H. et al. CXCL-10: a brand new candidate for melanoma remedy? Cell Oncol. 43, 353–365 (2020).
Home, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Most cancers Res. 26, 487–504 (2020).
Karin, N. CXCR3 ligands in most cancers and autoimmunity, chemoattraction of effector T cells, and past. Entrance. Immunol. 11, 976 (2020).
Ozga, A. J. et al. CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set level throughout power an infection. Immunity 55, 82–97 e88 (2022).
Silva-Santos, B., Serre, Ok. & Norell, H. γδ T cells in most cancers. Nat. Rev. Immunol. 15, 683–691 (2015).
Grasso, C. S. et al. Conserved interferon-γ signaling drives scientific response to immune checkpoint blockade remedy in melanoma. Most cancers Cell 38, 500–515 e503 (2020).
Larson, R. C. et al. CAR T cell killing requires the IFNγR pathway in strong however not liquid tumours. Nature 604, 563–570 (2022).
Abiko, Ok. et al. IFN-γ from lymphocytes induces PD-L1 expression and promotes development of ovarian most cancers. Br. J. Most cancers 112, 1501–1509 (2015).
Papadopoulou, M., Sanchez Sanchez, G. & Vermijlen, D. Innate and adaptive γδ T cells: how, when, and why. Immunol. Rev. 298, 99–116 (2020).
Bordon, Y. γδ T cells mediate immunotherapy responses when cancers lack MHC class I. Nat. Rev. Immunol. 23, 137 (2023).
Lien, S. C. et al. Tumor reactive γδ T cells contribute to a whole response to PD-1 blockade in a Merkel cell carcinoma affected person. Nat. Commun. 15, 1094 (2024).
Xu, J. et al. Yeast-derived nanoparticles rework the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor progress. Nat. Commun. 13, 110 (2022).
Fan, Q. et al. An implantable blood clot-based immune area of interest for enhanced most cancers vaccination. Sci. Adv. 6, eabb4639 (2020).
Han, X. et al. Crimson blood cell-derived nanoerythrosome for antigen supply with enhanced most cancers immunotherapy. Sci. Adv. 5, eaaw6870 (2019).
Zhu, H. et al. Human PBMC scRNA-seq-based getting old clocks reveal ribosome to irritation stability as a single-cell getting old hallmark and tremendous longevity. Sci. Adv. 9, eabq7599 (2023).